Key Takeaways and Special Moments
SABCS 2025
The largest breast cancer research
meeting in the world.
18 New Breast Cancer Drugs Approved in this Last Decade
Over the past decade, cancer immunotherapy has evolved from a promising concept into a mainstay of oncology practice, offering new hope amid rising cancer incidence worldwide. Increasing incidences of cancer diagnosis underscore the urgent need for more effective and durable treatment strategies. Unlike traditional treatments such as chemotherapy or radiation, immunotherapy offers targeted therapies designed to kill cancer cells while sparing healthy cells.
Poster Session
The Results of the Phase I Trial of the Cleveland Clinic's TNBC Vaccine
Advocate Judy Fitzgerald who has been with the program for 15 years bringing this vaccine from bench to bedside. Dr. Justin Johnson is the protegee of the Late Dr. Vincent Tuohy who invented the vaccine which took 3o years to achieve the Phase I Trial. Use the button below to access the Lay Language explanation of results.
.jpg)
Patient Advocate Judy Fitzgerald with an FDA Oncologist Mirat Shah. Judy was privileged to work with Dr. Shah on Project Optimus and on a panel for Friends of Cancer Research on Optimal Dosing...
FDA Oncology Center of Excellence
Patient Advocates had the opportunity to meet with six doctors from the FDA Breast Cancer Center of Excellence and ask questions and learn about the progress and challenges with new drug approval.
